Pardo-Montero Juan, González-Crespo Isabel, Gómez-Caamaño Antonio, Gago-Arias Araceli
Group of Medical Physics and Biomathematics, Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain.
Department of Medical Physics, Complexo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
Cancers (Basel). 2023 Jul 18;15(14):3659. doi: 10.3390/cancers15143659.
The purpose of this work was to investigate the response of prostate cancer to different radiotherapy schedules, including hypofractionation, to evaluate potential departures from the linear-quadratic (LQ) response, to obtain the best-fitting parameters for low-(LR), intermediate-(IR), and high-risk (HR) prostate cancer and to investigate the effect of ADT on the radiobiological response. We constructed a dataset of the dose-response containing 87 entries/16,536 patients (35/5181 LR, 32/8146 IR, 20/3209 HR), with doses per fraction ranging from 1.8 to 10 Gy. These data were fit to tumour control probability models based on the LQ model, linear-quadratic-linear (LQL) model, and a modification of the LQ (LQmod) model accounting for increasing radiosensitivity at large doses. Fits were performed with the maximum likelihood expectation methodology, and the Akaike information criterion (AIC) was used to compare the models. The AIC showed that the LQ model was superior to the LQL and LQmod models for all risks, except for IR, where the LQL model outperformed the other models. The analysis showed a low α/β for all risks: 2.0 Gy for LR (95% confidence interval: 1.7-2.3), 3.4 Gy for IR (3.0-4.0), and 2.8 Gy for HR (1.4-4.2). The best fits did not show proliferation for LR and showed moderate proliferation for IR/HR. The addition of ADT was consistent with a suppression of proliferation. In conclusion, the LQ model described the response of prostate cancer better than the alternative models. Only for IR, the LQL model outperformed the LQ model, pointing out a possible saturation of radiation damage with increasing dose. This study confirmed a low α/β for all risks.
本研究的目的是调查前列腺癌对不同放疗方案(包括大分割放疗)的反应,评估与线性二次(LQ)反应的潜在偏差,获得低危(LR)、中危(IR)和高危(HR)前列腺癌的最佳拟合参数,并研究雄激素剥夺治疗(ADT)对放射生物学反应的影响。我们构建了一个剂量反应数据集,包含87条记录/16536例患者(35/5181例LR,32/8146例IR,20/3209例HR),每次分割剂量范围为1.8至10 Gy。这些数据被拟合到基于LQ模型、线性二次线性(LQL)模型以及考虑大剂量时放射敏感性增加的LQ修正(LQmod)模型的肿瘤控制概率模型。采用最大似然期望方法进行拟合,并使用赤池信息准则(AIC)比较模型。AIC显示,对于所有风险组,LQ模型均优于LQL和LQmod模型,但IR组除外,在IR组中LQL模型表现优于其他模型。分析显示,所有风险组的α/β均较低:LR组为2.0 Gy(95%置信区间:1.7 - 2.3),IR组为3.4 Gy(3.0 - 4.0),HR组为2.8 Gy(1.4 - 4.2)。最佳拟合结果显示,LR组未显示增殖,IR/HR组显示中度增殖。添加ADT与增殖抑制一致。总之,LQ模型比其他替代模型更能描述前列腺癌的反应。仅在IR组中,LQL模型表现优于LQ模型,这表明随着剂量增加,辐射损伤可能存在饱和现象。本研究证实所有风险组的α/β均较低。